Premium
ALK‐negative anaplastic large cell lymphoma with urinary bladder involvement diagnosed in urine cytology: A case report and literature review
Author(s) -
Lobo João,
Henrique Rui,
Monteiro Paula,
Lobo Cláudia
Publication year - 2017
Publication title -
diagnostic cytopathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.417
H-Index - 65
eISSN - 1097-0339
pISSN - 8755-1039
DOI - 10.1002/dc.23669
Subject(s) - medicine , urine cytology , anaplastic large cell lymphoma , immunophenotyping , cystoscopy , cytology , pathology , anaplastic lymphoma kinase , cd30 , lymphoma , urinary bladder , urinary system , cytopathology , large cell , cancer , urology , adenocarcinoma , lung cancer , antigen , immunology , malignant pleural effusion
Anaplastic large cell lymphoma is an aggressive T‐cell neoplasm. It rarely involves the urinary bladder, with just twelve cases reported thus far and only one being ALK‐negative. Immunophenotyping (particularly for ALK) is mandatory, both for prognostic and therapeutic reasons. Herein, we report the case of a patient with an ALK‐negative anaplastic large cell lymphoma involving the bladder which was diagnosed and fully characterized by immunocytochemistry in urine cytology. The patient underwent a cystoscopy and the urine sample disclosed tumor diathesis background and aggregates of atypical cells, with evidence of multinucleation and mitotic figures. Immunocytochemistry revealed strong membrane/Golgi positivity for CD30 and negativity for ALK. The patient was submitted to transurethral resection for therapeutic purposes, which confirmed the diagnosis. To the best of our knowledge, this represents only the third case of anaplastic large cell lymphoma with bladder involvement diagnosed in urine cytology and the very first with diagnostic findings allowing for immunophenotyping of the disease in a bladder wash. The present report reinforces the role of urine cytology as a suitable method for establishing an earlier diagnosis and characterization of the disease, avoiding submitting patients to invasive procedures like transurethral resections. Diagn. Cytopathol. 2017;45:354–358. © 2016 Wiley Periodicals, Inc.